Advertisement

Design and evaluation of dual CD44 receptor and folate receptor-targeting double-smart pH-response multifunctional nanocarrier

  • Daquan ChenEmail author
  • Xiaoyan Song
  • Kaili Wang
  • Chunjing Guo
  • Yueming Yu
  • Huaying Fan
  • Feng Zhao
Brief Communication

Abstract

In this article, in order to enhance the bioavailiability and tumor targeting of curcumin (Cur), the oligosaccharides of hyaluronan conjugates, folic acid-oligosaccharides of hyaluronan-acetal-menthone 1,2-glycerol ketal (FA-oHA-Ace-MGK) carried oHA as a ligand to CD44 receptor, double-pH-sensitive Ace-MGK as hydrophobic moieties, and FA as the target of folate receptor. The structure characteristics of this smart response multifunctional dual-targeting nano-sized carrier was measured by fourier-transform infrared (FT-IR) and nuclear magnetic resonance (1H–NMR). Cur, an anticancer drug, was successfully loaded in FA-oHA-Ace-MGK micelles by self-assembly. The measurement results of transmission electron microscopy (TEM) presented that the Cur-loaded micelles were spherical in shape with the average size of 166.3 ± 2.12 nm and zeta potential − 30.07 mV. Much more encapsulated Cur could be released at mildly acidic environments than at pH 7.4, from the Cur-FA-oHA-Ace-MGK micelles. Cytotoxicity assay indicated that non-Cur loaded micelles mostly had no cytotoxicity to MCF-7 cells and A549 cells, and Cur-loaded micelles had significantly lower survival rate than Cur suspension in the same concentration, which proved that the drug-loaded micelles can effectively inhibit tumor cell growth. The targeting of CD44 receptors and folate receptors was proved in vitro cellular uptake assay. These results showed the promising potential of FA-oHA-Ace-MGK as an effective nano-sized carrier for anti-tumor drug delivery.

Keywords

CD44 receptor and folate receptor dual targeting Double pH-sensitivity Oligosaccharides of hyaluronan (oHA) conjugates Drug delivery Curcumin nanoparticles 

Notes

Author contributions

All the authors contributed equally to this work.

Funding information

This work was supported by the National Natural Science Foundation of China (No. 81573614), Young Taishan Scholar Program (No. qnts 20161035), the Graduate Innovation Foundation of Yantai University (No. YDYB1726), and the Technical Project of Yantai City (2015ZH079).

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflicts of interest.

References

  1. Buhrmann C, Kraehe P, Lueders C, Shayan P, Goel A, Shakibaei M (2014) Curcumin suppresses crosstalk between colon cancer stem cells and stromal fibroblasts in the tumor microenvironment: potential role of EMT. PLoS One 9(9):e107514.  https://doi.org/10.1371/journal.pone.0107514 CrossRefGoogle Scholar
  2. Charpentier MS, Whipple RA, Vitolo MI, Boggs AE, Slovic J, Thompson KN, Bhandary L, Martin SS (2014) Curcumin targets breast cancer stem-like cells with microtentacles that persist in mammospheres and promote reattachment. Cancer Res 74(4):1250–1260.  https://doi.org/10.1158/0008-5472.CAN-13-1778 CrossRefGoogle Scholar
  3. Chen D, Wang H (2014) Novel pH-sensitive biodegradable polymeric drug delivery systems based on ketal polymers. J Nanosci Nanotechnol 14(1):983–989.  https://doi.org/10.1166/jnn.2014.9190 CrossRefGoogle Scholar
  4. Chen D, Lian S, Liu Z, Zhao F, Jiang Y, Gao M, Sun K, Liu W, Fu F (2014a) Design of novel multifunctional targeting nano-carrier drug delivery system based on CD44 receptor and tumor microenvironment pH condition. Drug Deliv 3:1–6CrossRefGoogle Scholar
  5. Chen D, Sun J, Lian S, Liu Z, Sun K, Liu W, Wu Z, Zhang Q (2014b) Double pH-responsive and CD44 receptor targeted multifunctional nanoparticles for anticancer intracellular delivery. J Nanopart Res 16(11):2743.  https://doi.org/10.1007/s11051-014-2743-1 CrossRefGoogle Scholar
  6. Choi SW, Mason JB (2000) Folate and carcinogenesis: an integrated scheme. J Nutr 130(2):129–132Google Scholar
  7. Fang J, Nakamura H, Maeda H (2011) The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv Drug Deliv Rev 63(3):136–151.  https://doi.org/10.1016/j.addr.2010.04.009 CrossRefGoogle Scholar
  8. Ganta S, Devalapally H, Shahiwala A, Amiji M (2008) A review of stimuli-responsive nanocarriers for drug and gene delivery. Control Released 126(3):187–204.  https://doi.org/10.1016/j.jconrel.2007.12.017 CrossRefGoogle Scholar
  9. Guo X, Shi C, Wang J, Di S, Zhou S (2013) pH-triggered intracellular release from actively targeting polymer micelles. Biomaterials 34(18):4544–4554.  https://doi.org/10.1016/j.biomaterials.2013.02.071 CrossRefGoogle Scholar
  10. Hilgenbrink AR, Low PS (2005) Folate receptor-mediated drug targeting: from therapeutics to diagnostics. J Pharm Sci 94(10):2135–2146.  https://doi.org/10.1002/jps.20457 CrossRefGoogle Scholar
  11. Huang L, Liao M, Chen S, Demillo VG, Dupre SA, Zhu X, Publicover NG, Hunter KW Jr (2014) A polymer encapsulation approach to prepara zwitterion-like, biocompatible quantum dots with wide pH and ionic stability. J Nanopart Res 16(8):2555.  https://doi.org/10.1007/s11051-014-2555-3 CrossRefGoogle Scholar
  12. Lee H, Lee K, Park TG (2008) Hyaluronic acid-paclitaxel conjugate micelles: synthesis, characterization, and antitumor activity. Bioconjug Chem 19(6):1319–1325.  https://doi.org/10.1021/bc8000485 CrossRefGoogle Scholar
  13. Li M, Gao M, Fu YL, Chen C, Meng X, Fan AP, Kong DL, Wang Z, Zhao YJ (2016) Acetal-linked polymeric prodrug micelles for enhanced curcumin delivery. Colloids Surf B Biointerfaces 140:11–18.  https://doi.org/10.1016/j.colsurfb.2015.12.025 CrossRefGoogle Scholar
  14. Liu YH, Sun J, Cao W, Yang JY, Lian H, Li X, Sun Y, Wang YJ, Wang SL, He ZG (2011) Dual targeting folate-conjugated hyaluronic acid polymeric micelles for paclitaxel delivery. Pharmaceutics 421(1):160–169.  https://doi.org/10.1016/j.ijpharm.2011.09.006 CrossRefGoogle Scholar
  15. Low PS, Kularatne SA (2009) Folate-targeted therapeutic and imaging agents for cancer. Curr Opin Chem Biol 13:256e62CrossRefGoogle Scholar
  16. Lu YJ, Low PS (2002) Folate-mediated delivery of macromolecular anticancer therapeutic agents. Adv Drug Deliv Rev 54:675e93CrossRefGoogle Scholar
  17. Mottaghitalab F, Farokhi M, Shokrgozar MA, Atyabi F, Hosseinkhani H (2015) Silk fibroin nanoparticle as a noveldrug delivery system. J Control Release 206:161–176.  https://doi.org/10.1016/j.jconrel.2015.03.020 CrossRefGoogle Scholar
  18. Mukherjee D, Leo BF, Royce SG, Porter AE, Ryan MP, Schwander S, Chung KF, Tetley TD, Zhang J, Georgopoulos PG (2014a) Modeling physicochemical interactions affecting in vitro cellular dosimetry of engineered nanomaterials: application to nanosilver. J Nanopart Res 16(10):2616.  https://doi.org/10.1007/s11051-014-2616-7 CrossRefGoogle Scholar
  19. Mukherjee S, Mazumdar M, Chakraborty S, Manna A, Saha S, Khan P, Bhattacharjee P, Guha D, Adhikary A, Mukhjerjee S, Das T (2014b) Curcumin inhibits breast cancer stem cell migration by amplifying the E-cadherin/beta-catenin negative feedback loop. Stem Cell Res Ther 5(5):116.  https://doi.org/10.1186/scrt506 CrossRefGoogle Scholar
  20. Najafabadi AH, Abdouss M, Faghihi S (2014) Preparation and characterization of PEGylated chitosan nanocapsules as a carrier for pharmaceutical application. J Nanopart Res 16:1–14CrossRefGoogle Scholar
  21. Park JS, Han TH, Lee KY, Han SS, Hwang JJ, Moon DH, Kim SY, Cho YW (2006) N-acetyl histidine-conjugated glycol chitosan self-assembled nanoparticles for intracytoplasmic delivery of drugs: endocytosis, exocytosis and drug release. Control Release 115(1):37–45.  https://doi.org/10.1016/j.jconrel.2006.07.011 CrossRefGoogle Scholar
  22. Schulte PA, Geraci CL, Murashov V, Kuempel ED, Zumwalde RD, Castranova V, Hoover MD, Hodson L, Martinez KF (2014) Occupational safety and health criteria for responsible development of nanotechnology. J Nanopart Res 16(1):2153.  https://doi.org/10.1007/s11051-013-2153-9 CrossRefGoogle Scholar
  23. Sutton D, Nasongkla N, Blanceco E, Gao J(2007) Functionalized micellar systems for cancer targeted drug delivery. Pharm Res 24(6):1029–1046Google Scholar
  24. Taetz S, Bochot A, Surace C, Arpicco S, Renoir JM, Schaefer U, Marsaud V, Kerdine-Roemer S, Lehr CM, Fattal E (2009) Hyaluronic acid-modified DOTAP/DOPE liposomes for the targeted delivery of anti-telomerase siRNA to CD44-expressing lung cancer cells. Oligonucleotides 19(2):103–115.  https://doi.org/10.1089/oli.2008.0168 CrossRefGoogle Scholar
  25. Toffoli G, Cernigoi C, Russo A, Gallo A, Bagnoli M, Boiocchi M (1997) Overexpression of folate binding protein in ovarian cancers. Int J Cancer 74:193e8CrossRefGoogle Scholar
  26. Walczak AP, Hendriksen PJ, Woutersen RA, van der Zande M, Undas AK, Helsdingen R, van den Berg H, Rietjens IM, Bouwmeester H (2015) Bioavailability and biodistribution of differently charged polystyrene nanoparticles upon oral exposure in rats. J Nanopart Res 17(5):231.  https://doi.org/10.1007/s11051-015-3029-y CrossRefGoogle Scholar
  27. Wang S, Low PS (1998) Folate mediated targeting of antineoplastic drugs, imaging agents and nucleic acids to cancer cells. Control Release 53(123):39–48.  https://doi.org/10.1016/S0168-3659(97)00236-8 CrossRefGoogle Scholar
  28. Wang HJ, Zhao PQ, Liang XF, Gong XQ, Song T, Niu RF, Chang J (2010) Folate-PEG coated cationic modified chitosan-cholesterol liposomes for tumor-targeted drug deliver. Biomaterials 31(14):4129–4137CrossRefGoogle Scholar
  29. Xin DC, Wang Y, Xiang JN (2010) The use of amino acid linkers in the conjugation of paclitaxel with hyaluronic acid as drug delivery system: synthesis, self-assembled property, drug release, and in vitro efficiency. Pharm Res 27(2):380–389.  https://doi.org/10.1007/s11095-009-9997-9 CrossRefGoogle Scholar
  30. Yallapu MM, Khan S, Maher DM, Ebeling MC, Sundram V, Chauhan N, Ganju A, Balakrishna S, Gupta BK, Zafar N, Jaggi M, Chauhan SC (2014) Anti-cancer activity of curcumin loaded nanoparticles in prostate cancer. Biomaterials 35(30):8635–8648.  https://doi.org/10.1016/j.biomaterials.2014.06.040 CrossRefGoogle Scholar
  31. Yang C, Cao M, Liu H, He Y, Xu J, Du Y, Liu Y, Wang W, Cui L, Hu J, Cao F (2012) The high and low molecular weight forms of hyaluronan have distinct effects on CD44 clustering. J Biol Chem 287(51):43094–430107.  https://doi.org/10.1074/jbc.M112.349209 CrossRefGoogle Scholar
  32. Yu Y, Zhang X, Qiu L (2014) The anti-tumor efficacy of curcumin when delivered by size/charge-changing multistage polymeric micelles based on amphiphilic poly (β-amino ester) derivates. Biomaterials 35(10):3467–3479.  https://doi.org/10.1016/j.biomaterials.2013.12.096 CrossRefGoogle Scholar
  33. Zhao J, Riediker M (2014) Detecting the oxidative reactivity of nanoparticles: a new protocol for reducing artifacts. J Nanopart Res 16(7):2493.  https://doi.org/10.1007/s11051-014-2493-0 CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V., part of Springer Nature 2017

Authors and Affiliations

  1. 1.School of Pharmacy, Collaborative Innovation Center of Advanced Drug Delivery, System and Biotech Drugs in Universities of ShandongYantai UniversityShandong ShengChina
  2. 2.State Key Laboratory of Long-acting and Targeting Drug Delivery SystemYantaiChina

Personalised recommendations